You just read:

Mirati Announces Clinical Collaboration With Bristol-Myers Squibb For The Planned Phase 3 Trial In Non-Small Cell Lung Cancer To Evaluate Sitravatinib In Combination With Nivolumab (OPDIVO®)

News provided by

Mirati Therapeutics, Inc.

Jan 07, 2019, 08:30 ET